Pierre Charles

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 336 citations

Life Sciences, Immunology, Pharmacotherapy +15

Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study

Agnès Dechartres, Isabelle Boutron, Ludovic Trinquart et al. · Annals of Internal Medicine · 2011 · 318 citations

Public Health, Biostatistics, Clinical Epidemiology +16

Misrepresentation of Randomized Controlled Trials in Press Releases and News Coverage: A Cohort Study

Amélie Yavchitz, Isabelle Boutron, Aïda Bafeta et al. · PLoS Medicine · 2012 · 292 citations · Full text

Public Health, Biostatistics, Comparative Effectiveness Research +16

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody

Yves Allenbach, Y. Uzunhan, S. Toquet et al. · Neurology · 2020 · 251 citations · Full text

Life Sciences, Dermatology, Immunology +17